NR606 Week 7 Exam V2 | NR606 Diagnosis
& Management in Psychiatric-Mental
Health II Practicum | Q&A with Rationale
(NR606 Week 7 Exam) | Chamberlain
University
1. A 9-year-old child presents with significant inattention and hyperactivity at school and
home. Which of the following is considered the first-line pharmacological treatment for
ADHD in this age group?
A. Methylphenidate
B. Atomoxetine
C. Guanfacine
D. Clonidine
Answer: A
Rationale: Stimulant medications like methylphenidate are established as first-line
treatments for ADHD due to their high efficacy. They work primarily by increasing
dopamine and norepinephrine levels in the prefrontal cortex. Providers must monitor for
side effects such as appetite suppression and insomnia during follow-up visits.
2. When screening a 24-month-old child for Autism Spectrum Disorder (ASD), which tool is
most appropriate for clinical use?
A. PHQ-9
,B. Vanderbilt Assessment Scale
C. M-CHAT-R/F
D. SCARED
Answer: C
Rationale: The Modified Checklist for Autism in Toddlers, Revised with Follow-Up (M-
CHAT-R/F) is the gold standard for screening toddlers between 16 and 30 months. It
identifies children at risk for social communication deficits associated with ASD. Early
intervention following a positive screen significantly improves long-term developmental
outcomes.
3. Which FDA-approved medication is indicated for the treatment of Major Depressive
Disorder in a child who is 8 years old?
A. Sertraline
B. Escitalopram
C. Paroxetine
D. Fluoxetine
Answer: D
Rationale: Fluoxetine is the only antidepressant currently FDA-approved for the treatment
of Major Depressive Disorder in children as young as 8 years old. While other SSRIs may be
used off-label, fluoxetine has the most robust evidence for safety and efficacy in this
, specific pediatric demographic. Providers must counsel families on the Black Box Warning
regarding increased suicidal ideation.
4. A 14-year-old adolescent requires medication for Major Depressive Disorder. Which of the
following medications is FDA-approved for this indication starting at age 12?
A. Escitalopram
B. Citalopram
C. Venlafaxine
D. Amitriptyline
Answer: A
Rationale: Escitalopram is FDA-approved for the treatment of Major Depressive Disorder
in adolescents aged 12 to 17. It is often preferred due to its favorable side effect profile and
lower potential for drug-drug interactions compared to other SSRIs. Regular monitoring of
mood and potential activation symptoms is essential during the initial weeks of treatment.
5. Which family therapy model emphasizes the importance of boundaries, hierarchies, and
subsystems within the family unit?
A. Bowenian Family Therapy
B. Strategic Family Therapy
C. Structural Family Therapy
D. Solution-Focused Therapy
& Management in Psychiatric-Mental
Health II Practicum | Q&A with Rationale
(NR606 Week 7 Exam) | Chamberlain
University
1. A 9-year-old child presents with significant inattention and hyperactivity at school and
home. Which of the following is considered the first-line pharmacological treatment for
ADHD in this age group?
A. Methylphenidate
B. Atomoxetine
C. Guanfacine
D. Clonidine
Answer: A
Rationale: Stimulant medications like methylphenidate are established as first-line
treatments for ADHD due to their high efficacy. They work primarily by increasing
dopamine and norepinephrine levels in the prefrontal cortex. Providers must monitor for
side effects such as appetite suppression and insomnia during follow-up visits.
2. When screening a 24-month-old child for Autism Spectrum Disorder (ASD), which tool is
most appropriate for clinical use?
A. PHQ-9
,B. Vanderbilt Assessment Scale
C. M-CHAT-R/F
D. SCARED
Answer: C
Rationale: The Modified Checklist for Autism in Toddlers, Revised with Follow-Up (M-
CHAT-R/F) is the gold standard for screening toddlers between 16 and 30 months. It
identifies children at risk for social communication deficits associated with ASD. Early
intervention following a positive screen significantly improves long-term developmental
outcomes.
3. Which FDA-approved medication is indicated for the treatment of Major Depressive
Disorder in a child who is 8 years old?
A. Sertraline
B. Escitalopram
C. Paroxetine
D. Fluoxetine
Answer: D
Rationale: Fluoxetine is the only antidepressant currently FDA-approved for the treatment
of Major Depressive Disorder in children as young as 8 years old. While other SSRIs may be
used off-label, fluoxetine has the most robust evidence for safety and efficacy in this
, specific pediatric demographic. Providers must counsel families on the Black Box Warning
regarding increased suicidal ideation.
4. A 14-year-old adolescent requires medication for Major Depressive Disorder. Which of the
following medications is FDA-approved for this indication starting at age 12?
A. Escitalopram
B. Citalopram
C. Venlafaxine
D. Amitriptyline
Answer: A
Rationale: Escitalopram is FDA-approved for the treatment of Major Depressive Disorder
in adolescents aged 12 to 17. It is often preferred due to its favorable side effect profile and
lower potential for drug-drug interactions compared to other SSRIs. Regular monitoring of
mood and potential activation symptoms is essential during the initial weeks of treatment.
5. Which family therapy model emphasizes the importance of boundaries, hierarchies, and
subsystems within the family unit?
A. Bowenian Family Therapy
B. Strategic Family Therapy
C. Structural Family Therapy
D. Solution-Focused Therapy
